BioNTech SE (NASDAQ:BNTX) is included among the 10 Best Global Stocks to Buy According to Wall Street Analysts. BioNTech (BNTX) Price Target Raised Following Successful T-Pam Data BioNTech SE (NASDAQ:BNTX) is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases. On April 13, BofA raised its price target on BioNTech SE (NASDAQ:BNTX) from $128 to $130, while maintaining a ‘Buy’ rating on the shares. The revised target indicates an upside of almost ...